Andrei Stoica
Chief Tech/Sci/R&D Officer at BUTTERFLY NETWORK, INC.
Net worth: 2 M $ as of 2024-03-30
Profile
Andrei Stoica is currently the Chief Technology Officer at Butterfly Network, Inc. He previously worked as the Chief Technology Officer at BioTelemetry, Inc. and as the Vice President-Systems Development at IQVIA Holdings, Inc. He holds a doctorate degree from the University of South Carolina.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2024-04-01 | 1,497,558 ( 0.82% ) | 2 M $ | 2024-03-30 |
Andrei Stoica active positions
Companies | Position | Start |
---|---|---|
BUTTERFLY NETWORK, INC. | Chief Tech/Sci/R&D Officer | 2021-07-18 |
Former positions of Andrei Stoica
Companies | Position | End |
---|---|---|
BIOTELEMETRY, INC. | Chief Tech/Sci/R&D Officer | - |
IQVIA HOLDINGS INC. | Corporate Officer/Principal | - |
Training of Andrei Stoica
University of South Carolina | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
IQVIA HOLDINGS INC. | Health Services |
BUTTERFLY NETWORK, INC. | Health Technology |
Private companies | 1 |
---|---|
BioTelemetry, Inc.
BioTelemetry, Inc. Medical SpecialtiesHealth Technology BioTelemetry, Inc. provides monitoring services and digital population health management in a healthcare setting, medical device manufacturing and centralized core laboratory services for clinical research. The firm also develops proprietary integrated patient management platform that incorporates wireless data transmission network. It operates through the following segments: Healthcare, and Research. The Healthcare segment is focused on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders. The Research segment is engaged in central core laboratory services providing cardiac monitoring, imaging services, scientific consulting and data management services for drug and medical device trials. The company was founded on April 22, 2013 and is headquartered in Malvern, PA. | Health Technology |
- Stock Market
- Insiders
- Andrei Stoica